N-CAD levels and brain function in children with autism
Part of Brain & nervous system, Mental health clinical trials.
This study compares levels of a protein called N-CAD and brain function in children with autism spectrum disorder (ASD) versus typically developing children. It may help researchers understand how the brain works differently in autism.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be between 3 and 5 years old.
- Your child must have a diagnosis of autism spectrum disorder (ASD) from a specialist.
- Your child cannot have a genetic condition linked to ASD, like Rett syndrome.
- Your child cannot have medical or brain conditions like epilepsy, serious infections, or heart defects.
- Your child must not have vision or hearing loss.
- Your child must have had a birth weight of at least 4.4 pounds (2000 grams) and been born at 37 weeks or later.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares how children with and without autism show helpful and kind behaviors, and looks at brain scans to see related differences. It aims to understand the brain networks involved in social behavior.
This trial studies whether N-acetylcysteine, a medicine taken by mouth, can improve autism-related restricted and repetitive behaviors in children. It looks at children who are showing at least moderate severity in these behaviors and may involve brain testing for safety reasons.
This study looks at blood samples from children (and sometimes parents) to see if certain protein patterns can help identify or better understand autism spectrum disorder. The results could support finding “biomarkers,” which are measurable signs that may guide future research or care.
This study looks at how social behaviors and brain connections develop in infants who have a higher or lower chance of developing autism. It helps doctors understand early signs and may lead to better support for children and families.
This study looks for early brain markers (biomarkers) that predict autism, ADHD, and coordination difficulties in children and young adults. It also investigates why some young people with these conditions develop anxiety or depression, with the goal of better understanding and helping them.
This study looks at whether N-acetylcysteine (NAC), a supplement/medication, can help autism-related symptoms by trying to target brain chemistry. You may be able to join if you previously took part in a related NAC study and can keep your usual medications steady.
Hear when a new ASD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.